Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
20%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
XBI
137
HOLDINGS
16%
ALSO IN PBE
PBE
33
HOLDINGS
76%
ALSO IN XBI
SECTOR DRIFT (XBI minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
HALOZYME THERAPEUTICS INC | 1.4% | 2.6% | 1.4% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.3% | 3.0% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.3% | 4.7% | 1.3% |
|
AMGEN INC | 1.2% | 4.9% | 1.2% |
|
VERTEX PHARMACEUTICALS INC | 1.2% | 5.0% | 1.2% |
XBI Overweight Relative to PBE
|
MODERNA, INC. | 2.9% |
|
TWIST BIOSCIENCE CORP. | 1.7% |
|
NATERA INC | 1.4% |
|
KYMERA THERAPEUTICS, INC. | 1.4% |
|
REVOLUTION MEDICINES, INC. | 1.3% |
|
ORUKA THERAPEUTICS INC | 1.3% |
|
DIANTHUS THERAPEUTICS INC | 1.3% |
|
TRAVERE THERAPEUTICS, INC. | 1.3% |
|
INSMED INC | 1.3% |
|
CG ONCOLOGY, INC. | 1.3% |
XBI Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -4.8% |
|
BIOGEN IDEC INC | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -3.9% |
|
ALNYLAM PHARMACEUTICALS INC | -3.7% |
|
AMGEN INC | -3.7% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
REGENERON PHARMACEUTICALS | -3.4% |
|
GILEAD SCIENCES INC | -3.4% |
|
BIO-TECHNE CORPORATION | -3.2% |
|
REPLIGEN CORP | -3.0% |